New User? Sign Up | Sign In

Insider Trading - Black Diamond Therapeutics Inc. (BDTX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
BDTX Insider Trading Transactions for Black Diamond Therapeutics Inc.
Goto page 0, 1, 2, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-26
Sale
2020-10-28
5:51 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
8,903 $33.28 $296,293 5,699,671
(Indirect
Direct)
View
2020-10-26
Sale
2020-10-28
5:58 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
8,903 $33.28 $296,293 5,699,671
(Indirect
Direct)
View
2020-11-02
Sale
2020-11-03
7:56 pm
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
12,000 $31.14 $373,656 711,923
(Indirect
Direct)
View
2020-11-03
Sale
2020-11-04
8:37 pm
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $31.95 $79,873 0
(Direct)
View
2020-11-04
Sale
2020-11-06
4:44 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
11,348 $33.14 $376,127 5,689,647
(Indirect
Direct)
View
2020-11-04
Sale
2020-11-06
4:49 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
11,348 $33.14 $376,127 5,689,647
(Indirect
Direct)
View
2020-11-06
Sale
2020-11-10
7:24 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
9,400 $33.08 $310,949 5,681,344
(Indirect
Direct)
View
2020-11-06
Sale
2020-11-10
7:24 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
9,400 $33.08 $310,949 5,681,344
(Indirect
Direct)
View
2020-11-09
Sale
2020-11-12
5:00 pm
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $32.96 $98,892 0
(Direct)
View
2020-11-10
Sale
2020-11-12
5:38 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
39,583 $34.11 $1,350,354 5,646,377
(Indirect
Direct)
View
2020-11-10
Sale
2020-11-12
5:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
39,583 $34.11 $1,350,354 5,646,377
(Indirect
Direct)
View
2020-11-12
Sale
2020-11-13
4:25 pm
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $33.99 $138,607 3,000
(Direct)
View
2020-11-11
Sale
2020-11-13
4:26 pm
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
5,000 $34.9 $174,500 0
(Direct)
View
2020-11-11
Sale
2020-11-13
7:46 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
15,598 $34.15 $532,642 4,941,784
(Indirect
Direct)
View
2020-11-11
Sale
2020-11-13
7:47 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,598 $34.15 $532,642 4,941,784
(Indirect
Direct)
View
2020-11-13
Sale
2020-11-17
7:28 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
4,700 $33.74 $158,587 4,937,632
(Indirect
Direct)
View
2020-11-13
Sale
2020-11-17
7:33 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,700 $33.74 $158,587 4,937,632
(Indirect
Direct)
View
2020-11-17
Sale
2020-11-19
9:19 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,730 $33.05 $156,349 4,933,454
(Indirect
Direct)
View
2020-11-17
Sale
2020-11-19
9:19 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
4,730 $33.05 $156,349 4,933,454
(Indirect
Direct)
View
2020-11-19
Sale
2020-11-23
4:39 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
130,017 $33.01 $4,291,861 4,818,600
(Indirect
Direct)
View
2020-11-19
Sale
2020-11-23
4:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
130,017 $33.01 $4,291,861 4,818,600
(Indirect
Direct)
View
2020-11-27
Sale
2020-12-01
7:13 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
10,393 $33.15 $344,513 874,099
(Indirect
Direct)
View
2020-11-27
Sale
2020-12-01
7:13 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
10,393 $33.15 $344,513 874,099
(Indirect
Direct)
View
2020-12-01
Sale
2020-12-03
4:17 pm
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
12,000 $32.71 $392,574 702,923
(Indirect
Direct)
View
2020-12-03
Sale
2020-12-04
4:34 pm
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $32.42 $81,055 0
(Direct)
View
2020-12-08
Sale
2020-12-10
4:16 pm
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $33.78 $101,327 0
(Direct)
View
2020-12-14
Sale
2020-12-16
7:41 pm
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $34.95 $142,522 3,000
(Direct)
View
2021-01-04
Sale
2021-01-06
6:21 pm
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
12,000 $31.13 $373,505 696,423
(Indirect
Direct)
View
2021-01-04
Sale
2021-01-06
6:27 pm
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $31.41 $78,525 3,200
(Direct)
View
2021-01-08
Sale
2021-01-11
5:59 pm
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $33.94 $101,820 0
(Direct)
View
2021-01-12
Sale
2021-01-14
8:57 pm
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
11,578 $34.03 $394,041 8,400
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-11-02
Exercise
2020-11-03
7:56 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 711,923
(Direct)
View
2020-11-02
Exercise
2020-11-03
7:56 pm
N/A
2029-08-13
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 711,923
(Direct)
View
2020-11-03
Exercise
2020-11-04
8:37 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 0
(Direct)
View
2020-11-03
Exercise
2020-11-04
8:37 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 0
(Direct)
View
2020-11-09
Exercise
2020-11-12
5:00 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2020-11-09
Exercise
2020-11-12
5:00 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2020-11-12
Exercise
2020-11-13
4:25 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 3,000
(Direct)
View
2020-11-12
Exercise
2020-11-13
4:25 pm
N/A
2029-06-11
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 3,000
(Direct)
View
2020-11-11
Exercise
2020-11-13
4:26 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
5,000 $10.86 0
(Direct)
View
2020-11-11
Exercise
2020-11-13
4:26 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
5,000 $10.86 0
(Direct)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
690,814 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
13,816 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
13,816 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
11,918 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
11,918 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
3,954 $0 4,941,784
(Direct)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
199,652 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,071 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
59,534 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
3,211 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
4,282 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,502 $0 4,941,784
(Direct)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
690,814 $0 4,941,784
(Direct)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
13,816 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
13,816 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
11,918 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
11,918 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
199,652 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,071 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
59,534 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
3,211 $0 4,941,784
(Indirect)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,282 $0 4,941,784
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
476,659 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
9,533 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
9,533 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
8,223 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
8,223 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
2,728 $0 19,569
(Direct)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
84,462 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,269 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,269 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,258 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,258 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
43 $0 19,569
(Direct)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
154,671 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
828 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
46,121 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
2,488 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
3,316 $0 19,569
(Indirect)
View
2020-11-23
Other
2020-11-25
4:45 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
1,164 $0 19,569
(Direct)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
476,659 $0 0
(Direct)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
9,533 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
9,533 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
8,223 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
8,223 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
84,462 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,269 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,269 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,258 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,258 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
154,671 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
828 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
46,121 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
2,488 $0 0
(Indirect)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
3,316 $0 0
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
394,000 $0 874,099
(Direct)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
7,880 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
7,880 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
6,797 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
6,797 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
31,175 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
467 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
467 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
463 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
463 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
394,000 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
7,880 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
7,880 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
6,797 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
6,797 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
2,256 $0 874,099
(Direct)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
31,175 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
467 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
467 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
463 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
463 $0 874,099
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
15 $0 874,099
(Direct)
View
2020-12-01
Exercise
2020-12-03
4:17 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 702,923
(Direct)
View
2020-12-01
Exercise
2020-12-03
4:17 pm
N/A
2029-08-13
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 702,923
(Direct)
View
2020-12-03
Exercise
2020-12-04
4:34 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 0
(Direct)
View
2020-12-03
Exercise
2020-12-04
4:34 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 0
(Direct)
View
2020-12-08
Exercise
2020-12-10
4:16 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2020-12-08
Exercise
2020-12-10
4:16 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
20,784 $0 21,851
(Indirect)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
310 $0 21,851
(Indirect)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
310 $0 21,851
(Indirect)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
307 $0 21,851
(Indirect)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
307 $0 21,851
(Indirect)
View
2020-12-14
Other
2020-12-16
6:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
10% Owner
11 $0 21,851
(Direct)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
20,784 $0 0
(Indirect)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
310 $0 0
(Indirect)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
310 $0 0
(Indirect)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
307 $0 0
(Indirect)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
307 $0 0
(Indirect)
View
2020-12-15
Exercise
2020-12-16
7:39 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
2,500 $6.42 233,116
(Direct)
View
2020-12-15
Exercise
2020-12-16
7:39 pm
N/A
2029-08-13
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
2,500 $6.42 233,116
(Direct)
View
2020-12-14
Exercise
2020-12-16
7:41 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 3,000
(Direct)
View
2020-12-14
Exercise
2020-12-16
7:41 pm
N/A
2029-06-11
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 3,000
(Direct)
View
2020-12-15
Exercise
2020-12-16
7:42 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
3,200 $10.86 176,109
(Direct)
View
2020-12-15
Exercise
2020-12-16
7:42 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
3,200 $10.86 176,109
(Direct)
View
2020-12-15
Option Award
2020-12-16
7:42 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX INGRAM ROBERT ALEXANDER
Director
505 $34.29 5,505
(Direct)
View
2020-12-28
Exercise
2020-12-29
4:46 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
5,400 $3.2 180,864
(Direct)
View
2020-12-28
Exercise
2020-12-29
4:46 pm
N/A
2029-06-11
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
5,400 $3.2 180,864
(Direct)
View
2021-01-04
Exercise
2021-01-06
6:21 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 696,423
(Direct)
View
2021-01-04
Exercise
2021-01-06
6:21 pm
N/A
2029-08-13
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
3,000 $6.42 696,423
(Direct)
View
2021-01-04
Exercise
2021-01-06
6:27 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 3,200
(Direct)
View
2021-01-04
Exercise
2021-01-06
6:27 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
2,500 $10.86 3,200
(Direct)
View
2021-01-08
Exercise
2021-01-11
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2021-01-08
Exercise
2021-01-11
5:59 pm
N/A
2029-09-08
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
3,000 $10.86 0
(Direct)
View
2021-01-12
Exercise
2021-01-14
8:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 8,400
(Direct)
View
2021-01-12
Exercise
2021-01-14
8:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
7,500 $10.86 8,400
(Direct)
View
2021-01-12
Exercise
2021-01-14
8:57 pm
N/A
2029-06-11
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
4,078 $3.2 8,400
(Direct)
View
2021-01-12
Exercise
2021-01-14
8:57 pm
N/A
2029-12-04
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
7,500 $10.86 8,400
(Direct)
View
2021-01-19
Option Award
2021-01-22
4:59 pm
N/A
2031-01-19
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
29,842 $27.45 29,842
(Direct)
View
Goto page 0, 1, 2, Next